Your browser doesn't support javascript.
loading
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial.
Symmans, W Fraser; Yau, Christina; Chen, Yunn-Yi; Balassanian, Ron; Klein, Molly E; Pusztai, Lajos; Nanda, Rita; Parker, Barbara A; Datnow, Brian; Krings, Gregor; Wei, Shi; Feldman, Michael D; Duan, Xiuzhen; Chen, Beiyun; Sattar, Husain; Khazai, Laila; Zeck, Jay C; Sams, Sharon; Mhawech-Fauceglia, Paulette; Rendi, Mara; Sahoo, Sunati; Ocal, Idris Tolgay; Fan, Fang; LeBeau, Lauren Grasso; Vinh, Tuyethoa; Troxell, Megan L; Chien, A Jo; Wallace, Anne M; Forero-Torres, Andres; Ellis, Erin; Albain, Kathy S; Murthy, Rashmi K; Boughey, Judy C; Liu, Minetta C; Haley, Barbara B; Elias, Anthony D; Clark, Amy S; Kemmer, Kathleen; Isaacs, Claudine; Lang, Julie E; Han, Hyo S; Edmiston, Kirsten; Viscusi, Rebecca K; Northfelt, Donald W; Khan, Qamar J; Leyland-Jones, Brian; Venters, Sara J; Shad, Sonal; Matthews, Jeffrey B; Asare, Smita M.
Affiliation
  • Symmans WF; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston.
  • Yau C; Department of Surgery, University of California, San Francisco.
  • Chen YY; Department of Pathology, University of California, San Francisco.
  • Balassanian R; Department of Pathology, University of California, San Francisco.
  • Klein ME; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis.
  • Pusztai L; Department of Medicine, Medical Oncology, Yale University, New Haven, Connecticut.
  • Nanda R; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.
  • Parker BA; Division of Hematology-Oncology, Department of Medicine, University of California, San Diego, La Jolla.
  • Datnow B; Department of Pathology, University of California, San Diego, La Jolla.
  • Krings G; Department of Pathology, University of California, San Francisco.
  • Wei S; Department of Anatomic Pathology, University of Alabama at Birmingham.
  • Feldman MD; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia.
  • Duan X; Department of Pathology, Loyola University, Chicago, Illinois.
  • Chen B; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Sattar H; Department of Pathology, University of Chicago, Chicago, Illinois.
  • Khazai L; Department of Pathology, Moffitt Cancer Center, Tampa, Florida.
  • Zeck JC; Department of Pathology, Georgetown University, Washington, DC.
  • Sams S; Department of Pathology, University of Colorado Anschutz Medical Center, Aurora.
  • Mhawech-Fauceglia P; Department of Pathology, University of Southern California, Los Angeles.
  • Rendi M; Department of Anatomic Pathology, University of Washington, Seattle.
  • Sahoo S; Department of Pathology, University of Texas Southwestern, Dallas.
  • Ocal IT; Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona.
  • Fan F; Department of Pathology, University of Kansas Medical Center, Kansas City.
  • LeBeau LG; Department of Pathology, University of Arizona Health Sciences, Tucson.
  • Vinh T; Department of Pathology, Inova Health System, Fairfax, Virginia.
  • Troxell ML; Department of Pathology, Oregon Health and Science University, Portland.
  • Chien AJ; Division of Hematology-Oncology, Department of Medicine, University of California, San Francisco.
  • Wallace AM; Department of Surgery, University of California, San Diego, La Jolla.
  • Forero-Torres A; Division of Hematology-Oncology, Department of Medicine, University of Alabama at Birmingham.
  • Ellis E; Medical Oncology, Swedish Cancer Institute, Seattle, Washington.
  • Albain KS; Division of Hematology-Oncology, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Chicago, Illinois.
  • Murthy RK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Boughey JC; Department of Surgery, Mayo Clinic, Rochester, Minnesota.
  • Liu MC; Department of Oncology, Mayo Clinic, Rochester, Minnesota.
  • Haley BB; Division of Hematology-Oncology, Department of Medicine, UT Southwestern Medical Center, Dallas, Texas.
  • Elias AD; Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Center, Aurora.
  • Clark AS; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia.
  • Kemmer K; Division of Hematology-Oncology, Department of Medicine, Oregon Health & Science University, Portland.
  • Isaacs C; Division of Hematology-Oncology, Department of Medicine, Georgetown University, Washington, DC.
  • Lang JE; Department of Surgery, University of Southern California, Los Angeles.
  • Han HS; Department of Breast Oncology, Moffitt Cancer Center, Tampa, Florida.
  • Edmiston K; Department of Surgery, Inova Schar Cancer Institute, Fairfax, Virginia.
  • Viscusi RK; Department of Surgery, University of Arizona Health Sciences, Tucson, Arizona.
  • Northfelt DW; Department of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, Arizona.
  • Khan QJ; Division of Oncology, Department of Medicine, University of Kansas, Kansas City.
  • Leyland-Jones B; Medical Oncology, Avera Cancer Institute, Sioux Falls, South Dakota.
  • Venters SJ; Department of Laboratory Medicine, University of California, San Francisco.
  • Shad S; Department of Surgery, University of California, San Francisco.
  • Matthews JB; Department of Surgery, University of California, San Francisco.
  • Asare SM; Quantum Leap Healthcare Collaborative, San Francisco, California.
JAMA Oncol ; 7(11): 1654-1663, 2021 Nov 01.
Article in En | MEDLINE | ID: mdl-34529000
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Neoadjuvant Therapy Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: JAMA Oncol Year: 2021 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Neoadjuvant Therapy Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: JAMA Oncol Year: 2021 Document type: Article Country of publication: